SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
124.519 3.87 (3.21%)

NAV as on 02 Mar, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Jan 30, 15)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 95.26 24.46
Lupin Pharmaceuticals 52.28 13.43
Aurobindo Pharm Pharmaceuticals 40.56 10.42
Ranbaxy Labs Pharmaceuticals 31.66 8.13
Cadila Health Pharmaceuticals 24.59 6.32
Divis Labs Pharmaceuticals 22.65 5.82
Strides Arcolab Pharmaceuticals 22.37 5.75
Torrent Pharma Pharmaceuticals 21.47 5.52
Dr Reddys Labs Pharmaceuticals 12.95 3.33
Alembic Pharma Pharmaceuticals 12.72 3.27
Sector Allocation (Jan 30, 15)
  Sector   % 1-Year
High Low

Pharmaceuticals

98.52 99.60 96.68
Asset Allocation (%) (Jan 30, 15)
Class
%

Equity

98.52

Others / Unlisted

0.09

Debt

0.00

Mutual Funds

N.A

Money Market

3.81

Cash / Call

-2.42

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

62.76

Top 10

86.45
Sectors
%

Top 3

98.52
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.